Your Complete News View.
Published loading...Updated

Less than half of Americans trust FDA, CDC to do their job

  • On May 6, 2025, FDA Commissioner Dr. Marty Makary announced the agency is adopting a more cautious stance on COVID-19 booster approvals in Washington, D.C.
  • This cautious approach follows low booster uptake, notably 85% of healthcare workers skipping the last booster, prompting calls for rigorous clinical trials.
  • The FDA now requests full clinical trials from vaccine makers and considers limiting booster recommendations mainly to high-risk populations.
  • Makary emphasized the importance of relying on rigorous, up-to-date clinical trials rather than drawing conclusions from studies conducted several years ago, highlighting the need for high-quality scientific evidence.
  • This new policy may delay booster availability for the next respiratory season and reflects ongoing challenges in public trust and vaccine acceptance.
Insights by Ground AI
Does this summary seem wrong?

25 Articles

All
Left
4
Center
10
Right
4
InsideNoVA.comInsideNoVA.com
+13 Reposted by 13 other sources
Center

COVID Boosters Might Not Be Updated For Next Season, FDA Commissioner Says

Key Takeaways

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PHL17 broke the news in on Tuesday, May 6, 2025.
Sources are mostly out of (0)